Connection
John Rumsfeld to Peptides
This is a "connection" page, showing publications John Rumsfeld has written about Peptides.
|
|
Connection Strength |
|
 |
|
 |
|
0.082 |
|
|
|
-
Tsai TT, Maddox TM, Roe MT, Dai D, Alexander KP, Ho PM, Messenger JC, Nallamothu BK, Peterson ED, Rumsfeld JS. Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention. JAMA. 2009 Dec 09; 302(22):2458-64.
Score: 0.059
-
Barnes GD, Stanislawski MA, Liu W, Bar?n AE, Armstrong EJ, Ho PM, Klein A, Maddox TM, Nallamothu BK, Rumsfeld JS, Tsai TT, Bradley SM. Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. Circ Cardiovasc Qual Outcomes. 2016 07; 9(4):406-13.
Score: 0.023
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|